Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Atypical Femur Fracture, Atypical Subtrochanteric Fracture or Osteoporosis With AFf
and you are
between 20 and 100
years old
The phase for this study is not defined.
Show me locations

The purpose

Osteoporosis is a disease characterized by increased bone fragility and deteriorating bone micro-architecture. The main consequence of osteoporosis is low-trauma fractures, most often of the hip, spine and wrist. Recently, another type of low-trauma fracture, atypical femur fractures (AFFs), have received much attention. Little is known of the cause of these debilitating fractures; however, they have been associated with long term bisphosphonate use. What we currently know about AFFs is based on case reports or small case series, or studies using administrative databases or secondary analyses of bisphosphonate trials. While these reports provide some preliminary information on the relationship between long term bisphosphonate exposure and AFFs, detailed clinical data are absent. As we have established a network of specialists across southern Ontario our group is in a position to collect meaningful information on a larger group of patients who have experienced these debilitating fractures into a centralized AFF registry.
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01747291. The sponsor of the trial is University Health Network, Toronto and it is looking for 300 volunteers for the current phase.
Official trial title:
Atypical Femur Fracture Ontario Cohort Registry